Target
5-hydroxytryptamine receptor 3A
Ligand
BDBM50319676
Substrate
n/a
Meas. Tech.
ChEMBL_634700 (CHEMBL1118785)
IC50
5700±n/a nM
Citation
 Ghiron, CHaydar, SNAschmies, SBothmann, HCastaldo, CCocconcelli, GComery, TADi, LDunlop, JLock, TKramer, AKowal, DJow, FGrauer, SHarrison, BLa Rosa, SMaccari, LMarquis, KLMicco, INencini, AQuinn, JRobichaud, AJRoncarati, RScali, CTerstappen, GCTurlizzi, EValacchi, MVarrone, MZanaletti, RZanelli, U Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914). J Med Chem 53:4379-89 (2010) [PubMed]  Article 
Target
Name:
5-hydroxytryptamine receptor 3A
Synonyms:
5-HT-3 | 5-HT3 | 5-HT3A | 5-HT3R | 5-hydroxytryptamine receptor 3 (5-HT3) | 5-hydroxytryptamine receptor 3A (5-HT3a) | 5-hydroxytryptamine receptor 3A (5HT3A) | 5HT3A_HUMAN | 5HT3R | HTR3 | HTR3A | Serotonin 3 (5-HT3) receptor | Serotonin 3 receptor (5HT3) | Serotonin receptor 3A | Serotonin-gated ion channel receptor | Serotonin-gated ion channel receptor 3
Type:
Protein
Mol. Mass.:
55283.27
Organism:
Homo sapiens (Human)
Description:
P46098
Residue:
478
Sequence:
MLLWVQQALLALLLPTLLAQGEARRSRNTTRPALLRLSDYLLTNYRKGVRPVRDWRKPTTVSIDVIVYAILNVDEKNQVLTTYIWYRQYWTDEFLQWNPEDFDNITKLSIPTDSIWVPDILINEFVDVGKSPNIPYVYIRHQGEVQNYKPLQVVTACSLDIYNFPFDVQNCSLTFTSWLHTIQDINISLWRLPEKVKSDRSVFMNQGEWELLGVLPYFREFSMESSNYYAEMKFYVVIRRRPLFYVVSLLLPSIFLMVMDIVGFYLPPNSGERVSFKITLLLGYSVFLIIVSDTLPATAIGTPLIGVYFVVCMALLVISLAETIFIVRLVHKQDLQQPVPAWLRHLVLERIAWLLCLREQSTSQRPPATSQATKTDDCSAMGNHCSHMGGPQDFEKSPRDRCSPPPPPREASLAVCGLLQELSSIRQFLEKRDEIREVARDWLRVGSVLDKLLFHIYLLAVLAYSITLVMLWSIWQYA
  
Inhibitor
Name:
BDBM50319676
Synonyms:
1-(2'-fluorobiphenyl-4-yl)-3-(4-(piperidin-1-yl)butyl)urea | CHEMBL1085379
Type:
Small organic molecule
Emp. Form.:
C22H28FN3O
Mol. Mass.:
369.4756
SMILES:
Fc1ccccc1-c1ccc(NC(=O)NCCCCN2CCCCC2)cc1
Structure:
Search PDB for entries with ligand similarity: